Lv1
60 积分 2022-10-16 加入
Pathogenesis of Perianal Fistulising Crohn’s Disease: Current Knowledge, Gaps in Understanding, and Future Research Directions
5小时前
已完结
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
4个月前
已完结
Long-Term Outcomes of Intravenous Ustekinumab Maintenance Treatment in Patients With Loss of Response to Subcutaneous Dosing
5个月前
已完结
Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning
5个月前
已完结
Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?
5个月前
已完结
Ustekinumab Exposure-outcome Analysis in Crohn’s Disease Only in Part Explains Limited Endoscopic Remission Rates
5个月前
已完结
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
5个月前
已完结
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities
5个月前
已完结
Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease
5个月前
已完结
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn’s Disease
5个月前
已完结
皖公网安备34019202002308
